Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

5.510 -0.010 (-0.18%)
Streaming Delayed Price Updated: 12:12 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 303,318
Open 5.520
Bid (Size) 5.510 (309)
Ask (Size) 5.520 (29)
Prev. Close 5.520
Today's Range 5.510 - 5.540
52wk Range 2.600 - 5.650
Shares Outstanding 52,388,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SBOW, AGR, RPHM on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+35.05%
+35.05%
1 Month
+76.60%
+76.60%
3 Month
+42.38%
+42.38%
6 Month
+44.62%
+44.62%
1 Year
+98.92%
+98.92%

More News

Read More
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of Alimera Sciences's Earnings
Via Benzinga
The Latest Analyst Ratings for Alimera Sciences
Via Benzinga
Preview: Alimera Sciences's Earnings
Via Benzinga
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is MicroAlgo (MLGO) Stock Up 113% Today?
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
Via InvestorPlace
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
Via Benzinga
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Via Benzinga
Expert Ratings for Alimera Sciences
Via Benzinga
4 Analysts Have This to Say About Alimera Sciences
Via Benzinga
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
Via InvestorPlace
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
Via Newsfile
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.